Prognostic relevance of baseline pro- and anti-inflammatory markers in STEMI: an APEX AMI substudy.


BACKGROUND Plaque rupture, acute ischemia, and necrosis in acute coronary syndromes are accompanied by concurrent pro- and anti-inflammatory cascades. Whether STEMI clinical prediction models can be improved with the addition of baseline inflammatory biomarkers remains unknown. METHODS In an APEX-AMI trial substudy, 772 patients had a panel of 9… (More)
DOI: 10.1016/j.ijcard.2013.01.004


  • Presentations referencing similar topics